Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2015 Jul 26;90(9):1233–1246. doi: 10.1016/j.mayocp.2015.06.013

Figure 2. Epidemiology of NAFLD.

Figure 2

It is estimated that 3–12% of the US population is affected by NASH. 5 Although NASH patients have a higher risk of progression, it should be noted that some patients may progress directly from NAFL to advanced fibrosis. 12, 13 Approximately 2–3% of patients with NASH cirrhosis will develop HCC each year.26 Some NASH patients without cirrhosis may develop HCC, but the magnitude of risk is not clear.27, 28

sHCC = hepatocellular carcinoma; NAFL = nonalcoholic fatty liver; NAFLD = nonalcoholic fatty liver disease; NASH = nonalcoholic steatohepatitis; US = United States